Antibiotics (May 2020)

Mersaquinone, A New Tetracene Derivative from the Marine-Derived <i>Streptomyces</i> sp. EG1 Exhibiting Activity against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA)

  • Min Cheol Kim,
  • Reiko Cullum,
  • Ali M. S. Hebishy,
  • Hala A. Mohamed,
  • Ahmed H. I. Faraag,
  • Nehad M. Salah,
  • Mohamed S. Abdelfattah,
  • William Fenical

DOI
https://doi.org/10.3390/antibiotics9050252
Journal volume & issue
Vol. 9, no. 5
p. 252

Abstract

Read online

New antibiotics are desperately needed to overcome the societal challenges being encountered with methicillin-resistant Staphylococcus aureus (MRSA). In this study, a new tetracene derivative, named Mersaquinone (1), and the known Tetracenomycin D (2), Resistoflavin (3) and Resistomycin (4) have been isolated from the organic extract of the marine Streptomyces sp. EG1. The strain was isolated from a sediment sample collected from the North Coast of the Mediterranean Sea of Egypt. The chemical structure of Mersaquinone (1) was assigned based upon data from a diversity of spectroscopic techniques including HRESIMS, IR, 1D and 2D NMR measurements. Mersaquinone (1) showed antibacterial activity against methicillin-resistant Staphylococcus aureus with a minimum inhibitory concentration of 3.36 μg/mL.

Keywords